Transforming growth factor-β in in vivo resistance

Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

1967 • 10,659 citations

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

1980 • 4,407 citations

Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)

1993 • 755 citations

Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

1988 • 483 citations

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

1990 • 398 citations

Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

1993 • 318 citations

Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

1986 • 317 citations

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

1990 • 313 citations

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

1987 • 288 citations

One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.

1993 • 232 citations

Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes.

1994 • 166 citations

Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor β1

1994 • 150 citations

Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis

1994 • 147 citations

A major advance in the use of growth factors to enhance wound healing.

1993 • 95 citations

Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)

1991 • 87 citations

Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.

1987 • 77 citations

Post-transcriptional control of negative acute phase genes by transforming growth factor beta.

1989 • 74 citations

Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.

1994 • 69 citations

Development of alkylating agent-resistant human tumor cell lines

1988 • 48 citations

Induction of transforming growth factor beta in hormonally treated human prostate cancer

1994 • 36 citations

Resistance to Alkylating Agents: Basic Studies and Therapeutic Implications

1988 • 27 citations

Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors

1995 • 23 citations